Malnutrition and Cachexia

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Unknown venue

• Publication date

  2005-12-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1201/9780849333798.CH1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of omega-3 fatty acids on orexigenic and anorexigenic modulators at the onset of anorexia.

  2005cited by this paper
• Neuropeptide Y, α-melanocyte–stimulating hormone, and monoamines in food intake regulation

  2005cited by this paper
• The curse of the cure

  2005cited by this paper
• Hypothalamic 5-HT1B-receptor changes in anorectic tumor bearing rats.

  2005cited by this paper
• Therapy Insight: cancer anorexia–cachexia syndrome—when all you can eat is yourself

  2005cited by this paper
• Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin

  2004cited by this paper
• Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus.

  2004cited by this paper
• Upregulation of ghrelin expression in cachectic nude mice bearing human melanoma cells.

  2004cited by this paper
• Changes in hypothalamic neuropeptide Y and monoaminergic system in tumor-bearing rats: pre- and post-tumor resection and at death.

  2004cited by this paper
• Interleukin-1β system in anorectic catabolic tumor-bearing rats

  2004cited by this paper
• Tumor–host interactions

  2004cited by this paper
• Catabolic mediators as targets for cancer cachexia.

  2003cited by this paper
• Decreased NPY innervation of the hypothalamic nuclei in rats with cancer anorexia.

  2003cited by this paper
• Management of terminal cancer in elderly patients.

  2003cited by this paper
• What We Have Learned about Cachexia in Gastrointestinal Cancer

  2003cited by this paper
• Increased Muscle Proteasome Activity Correlates With Disease Severity in Gastric Cancer Patients

  2003cited by this paper
• Increased plasma ghrelin level in lung cancer cachexia.

  2003cited by this paper
• Anticancer drugs that induce cancer-associated cachectic syndromes

  2002cited by this paper
• Does leptin really influence cancer anorexia?

  2002cited by this paper
• Cancer Anorexia‐Cachexia Syndrome: Current Issues in Research and Management

  2002cited by this paper
• Activation of Central Melanocortin Pathways by Fenfluramine

  2002cited by this paper
• Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor

  2002cited by this paper
• Leptin and its relation to weight loss, ob gene expression and the acute‐phase response in surgical patients

  2001cited by this paper
• Serum leptin levels are higher but are not independently associated with severity or mortality in the multiple organ dysfunction/systemic inflammatory response syndrome: a matched case control and a longitudinal study

  2001cited by this paper
• Role of the central melanocortin system in cachexia.

  2001cited by this paper
• Cancer anorexia and cachexia.

  2001cited by this paper
• Metabolic abnormalities in cachexia and anorexia.

  2000cited by this paper
• Use of recombinant human soluble TNF receptor in anorectic tumor-bearing rats.

  1999cited by this paper
• Interleukin-1α Injection Into Ventromedial Hypothalamic Nucleus of Normal Rats Depresses Food Intake and Increases Release of Dopamine and Serotonin

  1999cited by this paper
• Cancer anorexia-cachexia syndrome: are neuropeptides the key?

  1999cited by this paper
• Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states.

  1999cited by this paper
• Purification and characterization of a tumor lipid-mobilizing factor.

  1998cited by this paper
• Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients.

  1998cited by this paper
• Effects of cachexia due to cancer on whole body and skeletal muscle protein turnover

  1998cited by this paper
• Anticytokine approaches to the treatment of anorexia and cachexia.

  1998cited by this paper
• Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition.

  1997cited by this paper
• Neural-immune interactions in health and disease.

  1997cited by this paper
• ABC of palliative care: Anorexia, cachexia, and nutrition

  1997cited by this paper
• Induction of muscle protein degradation by a tumour factor.

  1997cited by this paper
• Mechanism of early tumor anorexia.

  1996cited by this paper
• The relationship between weight loss and interleukin 6 in non-small-cell lung cancer.

  1996cited by this paper
• Analysis of the energy balance in lung cancer patients.

  1994cited by this paper
• Acute treatment with tumour necrosis factor-α induces changes in protein metabolism in rat skeletal muscle

  1993cited by this paper
• The early cancer anorexia paradigm: changes in plasma free tryptophan and feeding indexes.

  1992cited by this paper
• Nutritional support of the cancer patient

  1992cited by this paper
• Perioperative nutrition in cancer patients.

  1992cited by this paper
• A review of cancer cachexia and abnormal glucose metabolism in humans with cancer.

  1992cited by this paper
• Evidence for the involvement of interleukin 6 in experimental cancer cachexia.

  1992cited by this paper
• Hormonal Factors Associated with Weight Loss in Patients with Advanced Breast Cancer

  1991cited by this paper
• Effect of different tumor types on resting energy expenditure.

  1991cited by this paper
• The Roles of γ-Interferon and Tumor Necrosis Factor α in an Experimental Rat Model of Cancer Cachexia

  1991cited by this paper
• Interleukin-1-induced anorexia in the rat. Influence of prostaglandins.

  1989cited by this paper
• Cachectin/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity.

  1989cited by this paper
• Mediation of anorexia by human recombinant tumor necrosis factor through a peripheral action in the rat.

  1989cited by this paper
• Amino acid profiles in tumor‐bearing and pair‐fed nontumor‐bearing malnourished rats

  1988cited by this paper
• Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation

  1988cited by this paper
• Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings.

  1988cited by this paper
• Tumor necrosis factor not detectable in patients with clinical cancer cachexia.

  1988cited by this paper
• Induction of weight loss and metabolic alterations by human recombinant tumour necrosis factor.

  1988cited by this paper
• Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.

  1986cited by this paper
• Preoperative identification of the surgical cancer patient in need of postoperative supportive total parenteral nutrition

  1985cited by this paper
• Protein synthesis in the tumor-influenced hepatocyte.

  1985cited by this paper
• Tissue components of weight loss in cancer patients. A new method of study and preliminary observations

  1985cited by this paper
• Energy Expenditure in Malnourished Cancer Patients

  1983cited by this paper
• The influence of tumor-bearing on protein metabolism in the rat.

  1981cited by this paper
• In vivo utilization of substrate by human sarcoma‐bearing limbs

  1980cited by this paper
• Tumor host relations

  1979cited by this paper
• Causes of death in cancer patients

  1974cited by this paper

• 11 – Nutrition, Immunity, and Infection

  2015cites this paper
• Management of Anorexia-Cachexia in Late Stage Lung Cancer Patients.

  2012cites this paper